Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemia.
NPM1-mutated (NPM1c) acute myeloid leukemia (AML) has traditionally been considered a genetically defined entity associated with a favorable prognosis. However, growing evidence indicates that NPM1c A
